Last reviewed · How we verify
Popliteal Plexus Block with 10 ml
At a glance
| Generic name | Popliteal Plexus Block with 10 ml |
|---|---|
| Sponsor | Charlotte Runge |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of 10 Versus 20 mL Local Anesthetic for Popliteal Plexus Block on Opioid Consumption, Pain, and Patient-Reported Outcomes After Total Knee Arthroplasty (PHASE4)
- Comparison of Distal IPACK and Popliteal Plexus Block Combined With Femoral Triangle Block After Total Knee Arthroplasty (NA)
- Multimodal Analgesia Versus Peripheral Nerve Block for Postoperative Pain Management After Lower Limb Injury Surgery (NA)
- The Effect of PPB Using 10, 20 and 30 ml of Lidocaine, Study on Volunteers (PHASE4)
- Femoral Triangle Block With Popliteal Plexus Block Versus Femoral Triangle Block Versus Adductor Canal Block for TKA (PHASE4)
- Ultrasound-Guided Popliteal Plexus Block Versus Fascia Iliaca Block After Total Knee Arthroplasty (NA)
- Popliteal Plexus Block for Postoperative Pain After ACL Reconstruction (NA)
- The Effect of Popliteal Plexus Block on Pain After Total Knee Arthroplasty (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Popliteal Plexus Block with 10 ml CI brief — competitive landscape report
- Popliteal Plexus Block with 10 ml updates RSS · CI watch RSS
- Charlotte Runge portfolio CI